Share This

Create Your Own Business Intelligence Website   Input the stock code or the company name     Search   <06160.HK> - BEIGENE, LTD.    Stock Screener：Biotechnology, Biotechnology HUTCHMED INNOVATIVE PHAR UNI-BIO GROUP KING INTL INV BBI LIFE SCI ESSEX BIO-TECH JACOBIO-B CANBRIDGE-B 3D MEDICINES FUDANZHANGJIANG OCUMENSION-B FRONTAGE 3SBIO IMMUNEONCO-B GENSCRIPT BIO ASCLETIS-B INNOVENT BIO VIVA BIOTECH TOT BIOPHARM-B JUNSHI BIO EVEREST MED-B LAEKNA-B JW THERAP-B BRII-B HBM HOLDINGS-B LEPU BIO-B KEYMED BIO-B BASECARE-B CARSGEN-B RECBIO-B MABPHARM-B CLOVER BIO-B ABBISKO-B SIRNAOMICS-B WUXI XDC WUXI BIO BIOCYTOGEN-B MEILLEUREHEALTH WUXI APPTEC GIANT BIOGENE LUZHU BIOTECH-B CUTIA-B YZYBIO-B QYUNS-B HIGHTIDE-B HUA MEDICINE-B CSTONE PHARMA-B HENLIUS TIGERMED SINOMAB BIO-B CT ENTERPRISE AUSTAR JOINN CANSINOBIO SCICLONE PHARMA TRANSCENTA-B AIM VACCINE MEGA GENOMICS HAOHAI BIOTEC ASCENTAGE-B BOAN BIOTECH IMMUNOTECH-B SKB BIO-B ANTENGENE-B GENOR-B HAO WEN HLDGS HK LIFE SCI CRMI PFC DEVICE BIOSINO BIO-TEC NEP INTERLONG CORNERSTONE TEC HUAKANG BIOMED    Basic Datum Company name Lot P/E P/B EPS DPS BEIGENE 100 -21.69 4.2808 -5.0772 0.0 Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend    Related links    Related news    美生物法案擬限制與中資合作 據報歐美多家藥廠正物色替代外包供...   《大行》美銀證券降百濟神州目標價至99.21元 評級「中性」   高瓴轄下資產總值去年萎縮三分一 旗下基金據報面臨美投資者贖回   《大行報告》美銀證券升百濟神州目標價至108.27元 評級「...   《大行報告》里昂微升百濟神州目標價至138.5元 PD-1在...   百濟神州替雷利珠單抗獲美國批准治療食管鱗狀細胞癌  ≫More    Company Rating Date Broker Company name Rating Target 04-10     BEIGENE  中性 99.21 ≫More    Company performance - Published Date Company name Turnover* Profit* % Dividend ≫More    Comment 2020-03-04　百濟（6160）年內的研發成本高達9.27億元，按年增長36.57%，主要與澤布替尼和百澤安關鍵臨床試驗、後期候選藥物註冊登記、商業化前生產和供應、臨床前項目擴展及員工股權獎勵支出增加有關。   2020-03-04　百濟神州（6160）將就安進（4332）的三款商業階段藥物開展商業化發展，並對其20款候選藥物進行臨床開發。公司在未來兩年，預計將推進八款藥物上市及臨床開發。   2020-03-04　百濟神州（6160）去年第四季及全年的收入分別達到5689萬元美元及4.28億元，分別按年減少3.03%及大增1.16倍。百濟的銷售收入達2.23億元，按年增長70.1%，主要來自ABRAXANE、瑞復美和維達莎在內地銷售。澤布替尼更在美國食品藥品管理局批准一周之內商業上市，百澤安則獲內地國家藥品監督管理局批准，計劃於本月內上市。      Top Gain / Loss Show All Charts     Value Name Updated Value Change Change % HSI 04-23 09:30 16682.7 ▲ 171 ▲ 1.04% BEIGENE 04-25 16:09 90 ▲ 90 ▲ ∞% ≫More

Mobile | Full

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map

Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved

Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.